Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

公司概览
Cancer Biology Platform

思路迪医药致力于开发具有差异化的新一代肿瘤免疫治疗药物,延长肿瘤患者的生存时间,改善患者生活品质。公司现阶段管线包括两个临床阶段候选药物:全球*皮下注射PD-L1抗体KN035 (2017年FDA/NMPA/PMDA获准开展临床研究);高选择性FGFR-1/2/3抑制剂3D-185(思路迪医药拥有肿瘤和肺纤维化领域的全球开发权)。KN035全球共计六项临床试验在美、中、日同步进行,两项关键注册临床研究在中国开展,*适应症预计2020年提交上市申报。思路迪医药已经拥有一支国际化的新药开发团队,在全球同步开展临床试验和申报上市。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 15,000万(美元)
Legal Representative: 龚兆龙
Date Established:
Credit Code: 91320301MA23CD522L
Registered Address: 徐州市经济技术开发区徐州经济技术开发东湖医学创新港南侧、徐贾快速路东侧

People who follow this company also follow

Competitors (Similar Companies)

“中国中枢神经药物领域领先企业”
制药/药业 软膏剂 医药 抗生素
制药/药业 维生素 医药 抗生素
医药 研发 生产 制药
制药/药业 抗肿瘤药 肿瘤药物 医药
药物研发 生物制药 制药 抗肿瘤药
卫生材料 消毒用品 营养食品 中医药
制药/药业 医药 制药 原料药
资产管理 股权投资 新型城镇化 产业投资
“促进人类健康”
“释放城市未来生命力”
奶茶 冰淇淋 饮品 茶叶
医疗器械 检测设备 彩色多普勒超声 生产
“生物科技和生物活性材料”
医药 药物研发 中药研发 研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

便民回收
客服
由百度提供